Postmortem studies in psychiatry

H. S. Bracha, Joel Kleinman

Research output: Contribution to journalReview article

Abstract

Although biopsy material and in vivo neurochemical probes, such as positron emission tomography, offer alternative approaches, postmortem examination of the brain may never be completely replaced as a research tool in the study of neurologic and psychiatric diseases. This article discusses the advantage and disadvantages of this approach as well as some of the findings in neuropsychiatric illnesses. When considering the schizophrenic syndrome, one is struck by the number of positive findings. Unfortunately, most are not replicated. In addition confounding treatment effects of neuroleptics may account for many, if not all, of these findings. Nevertheless, one finds support here for the hypotheses that involve catecholamines and peptides in schizophrenic symptomatology. The problem is much the same with affective disorders and suicide. Nevertheless, most of the evidence may favor some disorder of the 5-HT system, probably at the receptor level. Perhaps the most significant 'breakthrough' in postmortem neurochemistry is in Alzheimer disease, in which the dementia and the decreased cholinergic activity appears related to the loss of cholinergic neurons from the nucleus basalis of Meynert. The findings in victims of suicide make one wonder if borderline personality disorder is not another worthwhile group to examine. Eating disorders and panic disorders may also warrant examination.

Original languageEnglish (US)
Pages (from-to)473-485
Number of pages13
JournalPsychiatric Clinics of North America
Volume7
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Suicide
Psychiatry
Basal Nucleus of Meynert
Neurochemistry
Borderline Personality Disorder
Cholinergic Neurons
Panic Disorder
Nervous System Diseases
Mood Disorders
Positron-Emission Tomography
Cholinergic Agents
Antipsychotic Agents
Catecholamines
Dementia
Autopsy
Serotonin
Alzheimer Disease
Biopsy
Peptides
Brain

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Postmortem studies in psychiatry. / Bracha, H. S.; Kleinman, Joel.

In: Psychiatric Clinics of North America, Vol. 7, No. 3, 1984, p. 473-485.

Research output: Contribution to journalReview article

Bracha, H. S. ; Kleinman, Joel. / Postmortem studies in psychiatry. In: Psychiatric Clinics of North America. 1984 ; Vol. 7, No. 3. pp. 473-485.
@article{0f6f8577e5804c619a25aba6294edccc,
title = "Postmortem studies in psychiatry",
abstract = "Although biopsy material and in vivo neurochemical probes, such as positron emission tomography, offer alternative approaches, postmortem examination of the brain may never be completely replaced as a research tool in the study of neurologic and psychiatric diseases. This article discusses the advantage and disadvantages of this approach as well as some of the findings in neuropsychiatric illnesses. When considering the schizophrenic syndrome, one is struck by the number of positive findings. Unfortunately, most are not replicated. In addition confounding treatment effects of neuroleptics may account for many, if not all, of these findings. Nevertheless, one finds support here for the hypotheses that involve catecholamines and peptides in schizophrenic symptomatology. The problem is much the same with affective disorders and suicide. Nevertheless, most of the evidence may favor some disorder of the 5-HT system, probably at the receptor level. Perhaps the most significant 'breakthrough' in postmortem neurochemistry is in Alzheimer disease, in which the dementia and the decreased cholinergic activity appears related to the loss of cholinergic neurons from the nucleus basalis of Meynert. The findings in victims of suicide make one wonder if borderline personality disorder is not another worthwhile group to examine. Eating disorders and panic disorders may also warrant examination.",
author = "Bracha, {H. S.} and Joel Kleinman",
year = "1984",
language = "English (US)",
volume = "7",
pages = "473--485",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Postmortem studies in psychiatry

AU - Bracha, H. S.

AU - Kleinman, Joel

PY - 1984

Y1 - 1984

N2 - Although biopsy material and in vivo neurochemical probes, such as positron emission tomography, offer alternative approaches, postmortem examination of the brain may never be completely replaced as a research tool in the study of neurologic and psychiatric diseases. This article discusses the advantage and disadvantages of this approach as well as some of the findings in neuropsychiatric illnesses. When considering the schizophrenic syndrome, one is struck by the number of positive findings. Unfortunately, most are not replicated. In addition confounding treatment effects of neuroleptics may account for many, if not all, of these findings. Nevertheless, one finds support here for the hypotheses that involve catecholamines and peptides in schizophrenic symptomatology. The problem is much the same with affective disorders and suicide. Nevertheless, most of the evidence may favor some disorder of the 5-HT system, probably at the receptor level. Perhaps the most significant 'breakthrough' in postmortem neurochemistry is in Alzheimer disease, in which the dementia and the decreased cholinergic activity appears related to the loss of cholinergic neurons from the nucleus basalis of Meynert. The findings in victims of suicide make one wonder if borderline personality disorder is not another worthwhile group to examine. Eating disorders and panic disorders may also warrant examination.

AB - Although biopsy material and in vivo neurochemical probes, such as positron emission tomography, offer alternative approaches, postmortem examination of the brain may never be completely replaced as a research tool in the study of neurologic and psychiatric diseases. This article discusses the advantage and disadvantages of this approach as well as some of the findings in neuropsychiatric illnesses. When considering the schizophrenic syndrome, one is struck by the number of positive findings. Unfortunately, most are not replicated. In addition confounding treatment effects of neuroleptics may account for many, if not all, of these findings. Nevertheless, one finds support here for the hypotheses that involve catecholamines and peptides in schizophrenic symptomatology. The problem is much the same with affective disorders and suicide. Nevertheless, most of the evidence may favor some disorder of the 5-HT system, probably at the receptor level. Perhaps the most significant 'breakthrough' in postmortem neurochemistry is in Alzheimer disease, in which the dementia and the decreased cholinergic activity appears related to the loss of cholinergic neurons from the nucleus basalis of Meynert. The findings in victims of suicide make one wonder if borderline personality disorder is not another worthwhile group to examine. Eating disorders and panic disorders may also warrant examination.

UR - http://www.scopus.com/inward/record.url?scp=0021599227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021599227&partnerID=8YFLogxK

M3 - Review article

C2 - 6384958

AN - SCOPUS:0021599227

VL - 7

SP - 473

EP - 485

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 3

ER -